|
Market Closed -
OTC Markets
09:53:26 2021-11-09 EST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
+9,900.00% | +9,900.00% |
| Market Cap | 1.04M 929K 857K 775K 1.45M 98.75M 1.47M 10.22M 4.08M 51.68M 3.89M 3.81M 164M | P/E 2015 |
-0.75x | P/E 2016 | -0.29x |
|---|---|---|---|---|---|
| Enterprise Value | -11.07M -9.92M -9.15M -8.28M -15.48M -1.05B -15.73M -109M -43.55M -552M -41.56M -40.67M -1.75B | EV / Sales 2015 |
-616,781,247x | EV / Sales 2016 | - |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | +9,900.00% | ||
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 1 month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0 | |
| 10 years | 0 | 0 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Talari
CEO | Chief Executive Officer | 64 | 2014-08-13 |
John Verghese
COO | Chief Operating Officer | 66 | - |
Karin Rohret
AUD | Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sam Talari
CHM | Chairman | 64 | 2014-08-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | +9,900.00% | +9,900.00% | +900.00% | 8.39K | ||
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | ||
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | ||
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | ||
| +0.42% | +3.15% | +54.07% | +67.09% | 388B | ||
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | ||
| +1.38% | +4.89% | +35.78% | +58.64% | 302B | ||
| +5.45% | +7.42% | +9.80% | +34.82% | 271B | ||
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | ||
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | ||
| Average | +992.10% | +2.33% | +1,031.18% | +163.87% | 417.68B | |
| Weighted average by Cap. | +2.12% | +3.04% | +50.92% | +96.75% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 0.05 0.05 0.04 0.04 0.08 5.14 0.08 0.53 0.21 2.69 0.2 0.2 8.52 | - |
| Net income | -1.41M -1.26M -1.16M -1.05M -1.96M -134M -2M -13.85M -5.53M -70.03M -5.27M -5.16M -222M | -644K -577K -532K -482K -901K -61.36M -916K -6.35M -2.53M -32.11M -2.42M -2.37M -102M |
| Net Debt | -34.28M -30.71M -28.33M -25.64M -47.94M -3.26B -48.71M -338M -135M -1.71B -129M -126M -5.41B | -12.11M -10.85M -10.01M -9.06M -16.93M -1.15B -17.21M -119M -47.63M -604M -45.45M -44.48M -1.91B |
Employees
8
Sector
Pharmaceuticals
- Stock Market
- Stocks
- FWDG Stock
Select your edition
All financial news and data tailored to specific country editions
















